Department of Surgery

Fatty acids rewire energy supply chain in stomach cancer development

A study by Vanderbilt researchers has revealed how metabolic changes spurred by fatty acids contribute to the transformation of cells into abnormal versions of themselves that are the precursors to stomach cancer.

Transplant patient Connie Rankin was cleared to return home to Memphis just in time for the holidays. (photo by Erin O. Smith)

VUMC performs its first combined lung and liver transplant

Connie Rankin of Memphis, Tennessee, received Vanderbilt’s first combined lung and liver transplant, which involved dozens of specialists, including transplant teams for both organs.

VUMC seeks public input on blood-clotting agent study

Researchers at Vanderbilt are considering participation in an international study to examine if a blood-clotting medication given to adults with major bleeding or in need of urgent surgery or an invasive procedure can improve survival.

Blane Hollingsworth, PhD, was the first patient at VUMC to undergo a liver transplant under the protocol for cholangiocarcinoma.

Multidisciplinary care crucial in guiding Vanderbilt employee’s bile duct cancer journey

Blane Hollingsworth became the first patient at Vanderbilt to undergo a liver transplant under the protocol for cholangiocarcinoma, or bile duct cancer.

x-ray of stomach

Study validates pyrvinium as treatment to prevent stomach cancer

A Vanderbilt study found that a drug that has been used for decades for intestinal pinworms, can be repurposed as a preventative treatment for stomach cancer.

Surgeons to lead multisite study of procedure to limit blood loss by partially blocking aorta

Vanderbilt care surgeons are leading a two-year, multicenter observational study of a minimally invasive technique to control life-threatening blood loss by inserting a balloon inside the aorta to restrict blood flow below the heart.

1 2 3 4 5 12